Additionally, we confirmed the nuclear localization of endogenous CRP2 in another triple-negative breast cancer cell line, namely, MDA-MB-468 (Supplementary Figures S1B, C), suggesting that this phenomenon is not limited to MDA-MB-231 cells. Here, CRIP2 is linked to triple-negative breast carcinoma.